Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intramuscular Olanzapine Versus Haloperidol or Midazolam for the Management of Acute Agitation in the Emergency Department - a Multicentre Randomised Clinical Trial

NCT02380118 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT02380118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02380118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intramuscular Olanzapine Versus Haloperidol or Midazolam for the Management of Acute Agitation in the Emergency Department - a Multicentre Randomised Clinical Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2014
Completion date
September 30, 2019
Enrollment
167 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute agitation, behavioural emergency